Protective effect of GK2 fused BLVRA protein against oxidative stress‐induced dopaminergic neuronal cell damage
The FEBS Journal · 2023
DOI: 10.1111/febs.16721 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2023. Verfasst von Yeon Joo Choi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon, South Korea. Hauptthemen laut MEDLINE: Neuroblastoma, Parkinson Disease, Neuroprotective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
It is well known that oxidative stress is highly associated with Parkinson's disease (PD), and biliverdin reductase A (BLVRA) is known to have antioxidant properties against oxidative stress. In this study, we developed a novel N‐acetylgalactosamine kinase (GK2) protein transduction domain (PTD) derived from adenosine A2A and fused with BLVRA to determine whether the GK2‐BLVRA fusion protein could protect dopaminergic neuronal cells (SH‐SY5Y) from oxidative stress in vitro and in vivo using a PD animal model. GK2‐BLVRA was transduced into various cells, including SH‐SY5Y cells, without cytotoxic effects, and this fusion protein protected SH‐SY5Y cells and reduced reactive oxygen species production and DNA damage after 1‐methyl‐4‐phenylpyridinium (MPP + ) exposure. GK2‐BLVRA suppressed mitogen‐activated protein kinase (MAPK) activation and modulated apoptosis‐related protein (Bcl‐2, Bax, cleaved Caspase‐3 and ‐9) expression levels. In the PD animal model, GK2‐BLVRA transduced into the substantia nigra crossed the blood–brain barrier and markedly reduced dopaminergic neuronal cell death in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced animals. These results indicate that our novel PTD GK‐2 is useful for the transduction of protein, and GK2‐BLVRA exhibits a beneficial effect against dopaminergic neuronal cell death in vitro and in vivo , suggesting that BLVRA can be used as a therapeutic agent for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon, South Korea.
- Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, South Korea.
- Department of Anatomy and BK21 FOUR Project, College of Medicine, Soonchunhyang University, Cheonan-si, South Korea.
ORCID-Profile: Won Sik Eum, Soo Young Choi
Zitieren
APA
Choi, Y. J., Kwon, H. J., Shin, M. J., Kim, D. W., Youn, G. S., Park, J. H., Yeo, H. J., Yeo, E. J., Kim, H. S., Lee, L. R., Kim, N. Y., Kwon, S. Y., Kim, D. S., Kim, G. W., Park, J., Han, K. H., Lee, K. W., Park, J. K., Lee, C. H., …, & Choi, S. Y. (2023). Protective effect of GK2 fused BLVRA protein against oxidative stress‐induced dopaminergic neuronal cell damage. The FEBS Journal. https://doi.org/10.1111/febs.16721
Vancouver
Choi YJ, Kwon HJ, Shin MJ, Kim DW, Youn GS, Park JH, et al. Protective effect of GK2 fused BLVRA protein against oxidative stress‐induced dopaminergic neuronal cell damage. The FEBS Journal. 2023. doi:10.1111/febs.16721
BibTeX
@article{Choi2023,
author = {Choi, Yeon Joo and Kwon, Hyun Jung and Shin, Min Jea and Kim, Dae Won and Youn, Gi Soo and Park, Jung Hwan and Yeo, Hyeon Ji and Yeo, Eun Ji and Kim, Hyeong Seop and Lee, Lee Re and Kim, Na Yeon and Kwon, Su Yeon and Kim, Duk-Soo and Kim, Gun Woo and Park, Jinseu and Han, Kyu Hyung and Lee, Keun Wook and Park, Jong Kook and Lee, Chan Hee and Eum, Won Sik and Choi, Soo Young},
title = {Protective effect of GK2 fused BLVRA protein against oxidative stress‐induced dopaminergic neuronal cell damage},
journal = {The FEBS Journal},
year = {2023},
doi = {10.1111/febs.16721}
}
EUVIMED